Search results
Added:
1 year ago
In this Meet the Experts session, from e-SPACE Heart Failure 2024, Prof Gerasimos Filippatos and Prof Muthiah Vaduganathan explore the evolving role of non-steroidal MRAs in heart failure management.
View more
Added:
1 year ago
In this symposium, from e-SPACE Heart Failure 2024, Prof Stefan Anker, Prof Biykem Bozkurt, Prof Michael Böhm and Prof Clara Ines Saldarriaga provide updates on the prevention and treatment of heart failure using SGLT2 inhibitors.
View more
Added:
1 year ago
Prof Gianluigi Savarese presents a second case study of a HFrEF patient with worsening heart failure symptoms in the outpatient clinic. The patient is already prescribed GDMT and a loop diuretic, Professor Savarese asks, ‘what are the next steps in managing this patient?’.Watch the second case by Gianluigi Savarese on Worsening Heart Failure – Inpatient Setting and a case from Javed Butler who…
View more
Added:
1 year ago
Prof Gianluigi Savarese presents a case study of a HFrEF patient with a history of disease progression and worsening of symptoms despite GDMT. The patient is admitted for IV diuresis and Professor Savarese asks, ‘what are the next steps in managing this patient?' Watch the second case by Gianluigi Savarese on Worsening Heart Failure – Outpatient Setting and a case from Javed Butler who present on…
View more
Added:
11 months ago
ESC HF 25 - VELOCITY shows bypassing an initiation dose of 2.5mg, and and beginning with 5mg vericiguat safe and tolerable in 9/10 patients with heart failure with ejection fraction <45%.Prof Stephen Greene (Duke Clinical Research Institute, US) discusses the findings from VELOCITY (NCT06195930; Bayer), a phase 2b open-label clinical study evaluating the tolerability and safety of an…
View more
Added:
5 months ago
AHA Scientific Sessions 2025 – Dr Ambarish Pandey (University of Texas Southwestern Medical Center, US) presents findings from a randomized clinical trial comparing medically tailored meals versus produce supplements on heart failure readmissions and emergency department visits.The study was conducted across two centers in Dallas, Texas. Patients were randomized within two weeks following heart…
View more
Added:
5 months ago
AHA Scientific Sessions 2025 – Dr Ambarish Pandey (University of Texas Southwestern Medical Center, US) presents results from the POLY-HF trial (NCT04633005), evaluating a polypill strategy combining multiple evidence-based medications for heart failure with reduced ejection fraction.This single-center randomized trial enrolled 212 patients with HFrEF (ejection fraction ≤40%) who were not…
View more
Added:
1 year ago
HFA 24 - Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE) joins us in this succinct interview to outline the findings of the RELIEVE-HF trial (NCT03499236).RELIEVE-HF was designed to evaluate the safety and effectiveness of the V-Wave inter-atrial shunt system to reduce lung congestion in patients with advanced heart failure. 605 participants with New York Heart Association (NYHA)…
View more
ESC 24: MRAs in HF
Added:
1 year ago
Video
Added:
9 months ago
In this short interview, we are joined by Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) to discuss the key updates and recommendations from the 2025 ACC Scientific Statement on the Management of Obesity in Adults with Heart Failure.Interview Questions:1. What is the current research landscape for heart failure patients with obesity?2. What are the new recommendations in this scientific…
View more